acetylglucosamine has been researched along with HIV Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Maier, I | 1 |
Bélec, L; Magri, G; Nasreddine, N; Réquena, M; Saïdi, H | 1 |
2 other study(ies) available for acetylglucosamine and HIV Infections
Article | Year |
---|---|
Engineering recombinantly expressed lectin-based antiviral agents.
Topics: Acetylglucosamine; Antiviral Agents; Binding Sites; Broadly Neutralizing Antibodies; Carrier Proteins; COVID-19; Disulfides; Glycoproteins; Hemagglutinins; HIV Infections; HIV-1; Humans; Lectins; Mannose; Oligosaccharides; Peptides; Polysaccharides; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |
R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: implication for mechanisms of sexual transmission.
Topics: Acetylglucosamine; Anti-HIV Agents; CCR5 Receptor Antagonists; Cell Line; Chemokine CXCL1; Chemokines, CXC; Endocytosis; Endometrium; Epithelial Cells; Female; Fucose; Heparan Sulfate Proteoglycans; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Interleukin-1alpha; Interleukin-8; Lectins, C-Type; Mannose; Mannose Receptor; Mannose-Binding Lectins; Receptors, CCR5; Receptors, Cell Surface; Receptors, CXCR4; Tumor Necrosis Factor-alpha; Virulence; Virus Attachment | 2007 |